CLINICAL_TRIALS trial_result · 2014-12-22

Clinical Trial Update: High-dose Bevacizumab in Advanced Renal Carcinoma Patients [Phase 2]

A Phase 2 trial evaluated high-dose bevacizumab in patients with advanced renal cell carcinoma; results were posted December 22, 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: SCRI Development Innovations, LLC | Conditions: Renal Cancer, Kidney Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-12-22